Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

Share Price is delayed by 15 minutes
Get Live Data
0.175    -0.0165 (-8.62%)
Bid:
0.17
Ask:
0.18
Spread: 0.01 (5.882%)
Market Cap: £7.51m
OBD Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biodyn Share Chart

Holding(s) in Company

5 Feb 2025 14:11

RNS Number : 0570W
Oxford BioDynamics PLC
05 February 2025
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biodynamics plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Unicorn Asset Management Limited

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Unicorn AIM VCT plc

City and country of registered office (if applicable)

Teignmouth, Devon, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

03 February 2025

6. Date on which issuer notified (DD/MM/YYYY):

05 February 2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

23.00%

23.00%

145,131,526

Position of previous notification (if

applicable)

7.94%

7.94%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares GB00BD5H8572

145,131,526

23.00%

SUBTOTAL 8. A

145,131,526

23.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Figures are based on total voting rights of 630,919,226

 

Place of completion

Unicorn Asset Management Limited, Preachers Court, Charterhouse, Charterhouse Square, London, EC1M 6AU

Date of completion

05 February 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALASEENSEFA
Date   Source Headline
18th Nov 20224:35 pmRNSPrice Monitoring Extension
14th Nov 202211:10 amRNSDirector/PDMR Shareholding
9th Nov 20224:07 pmRNSDirector/PDMR Shareholding
8th Nov 20221:57 pmRNSHolding(s) in Company
2nd Nov 202212:37 pmRNSHolding(s) in Company
2nd Nov 202212:35 pmRNSHolding(s) in Company
2nd Nov 202212:33 pmRNSHolding(s) in Company
1st Nov 20221:20 pmRNSTotal Voting Rights
1st Nov 202212:39 pmRNSTotal Voting Rights
1st Nov 202210:57 amRNSHolding(s) in Company
31st Oct 202211:05 amRNSHolding(s) in Company
31st Oct 202211:04 amRNSHolding(s) in Company
31st Oct 202211:02 amRNSHolding(s) in Company
31st Oct 202210:58 amRNSHolding(s) in Company
31st Oct 202210:57 amRNSHolding(s) in Company
31st Oct 202210:56 amRNSHolding(s) in Company
28th Oct 20222:36 pmRNSHolding(s) in Company
27th Oct 202212:09 pmRNSResult of General Meeting, Director/PDMR Dealings
25th Oct 20222:30 pmRNSResult of Open Offer
7th Oct 202212:00 pmRNSProposed Placing and Open Offer
3rd Oct 20227:00 amRNSUS Reimbursement Code for CiRT now available
15th Sep 20227:00 amRNSESMO data highlights unique benefit of EpiSwitch
6th Sep 20227:00 amRNSCiRT highlighted at ESMO 2022 presentation
5th Jul 20227:00 amRNSUS reimbursement code for EpiSwitch® CiRT
1st Jul 20224:13 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSHalf-year Report
21st Jun 20227:00 amRNSEpiSwitch® CiRT now available in the UK
17th Jun 20227:00 amRNSNotice of Interim Results Webinar
15th Jun 20227:00 amRNSNotice of Results
14th Jun 20227:00 amRNSOBD EpiSwitch® CiRT well received at ASCO 2022
20th May 20223:50 pmRNSDirector/PDMR Shareholding
20th May 20227:00 amRNSPDMR Dealing / Grant of Share Options
13th May 20223:57 pmRNSPDMR Dealing / Grant of Share Options
5th May 20227:00 amRNSOBD to present CiRT clinical utility data at ASCO
28th Apr 202210:54 amRNSDirector/PDMR Shareholding
11th Apr 202212:00 pmRNSHolding(s) in Company
8th Apr 202210:40 amRNSPDMR Dealing
7th Apr 202210:36 amRNSPDMR Dealing
6th Apr 20224:14 pmRNSPDMR Dealing
6th Apr 20224:03 pmRNSPDMR Dealing
30th Mar 20222:09 pmRNSResults of Annual General Meeting
4th Mar 20229:42 amRNSPDMR Dealing
3rd Mar 20229:58 amRNSPDMR Dealing
1st Mar 20224:16 pmRNSPUBLICATION OF 2021 ANNUAL REPORT
25th Feb 20227:00 amRNSUS launch of EpiSwitch® CiRT for oncology
15th Feb 202210:17 amRNSPDMR Dealing
10th Feb 202211:52 amRNSPDMR Dealing
8th Feb 20223:10 pmRNSHolding(s) in Company
7th Feb 20222:47 pmRNSPDMR Dealing
26th Jan 20229:50 amRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.